Metagenomic sequencing with the Oxford Nanopore MinION sequencer offers potential for point-of-care testing of infectious diseases in clinical settings. To improve cost-effectiveness, multiplexing of several, barcoded samples upon a single flow cell will be required during sequencing. We generated a unique sequencing dataset to assess the extent and source of cross barcode contamination caused by multiplex MinION sequencing. Sequencing libraries for three different viruses, including influenza A, dengue, and chikungunya, were prepared separately and sequenced on individual flow cells. We also pooled the respective libraries and performed multiplex sequencing. We identified 0.056% of total reads in the multiplex sequencing data that were ass...
Abstract Since the development of Sanger sequencing in 1977, sequencing technology has played a pivo...
Whole genome sequencing can be used to characterize and to trace viral outbreaks. Nanopore-based who...
The infrastructure challenges and costs of next-generation sequencing have been largely overcome, fo...
Metagenomic sequencing with the Oxford Nanopore MinION sequencer offers potential for point-of-care ...
Metagenomic sequencing with the Oxford Nanopore MinION sequencer offers potential for point-of-care ...
The use of the MinION sequencer (Oxford Nanopore) was tested on samples prepared to simulate infecti...
© 2015 Greninger et al.We report unbiased metagenomic detection of chikungunya virus (CHIKV), Ebola ...
As exemplified by the global response to the SARS-CoV-2 pandemic, whole-genome sequencing played an ...
Laboratories studying high-priority pathogens need comprehensive methods to confirm microbial specie...
Recently, protocols for amplicon based whole genome sequencing using Nanopore technology have been d...
Shotgun metagenomic sequencing (SMg) enables the simultaneous detection and characterization of viru...
Influenza is a major global public health threat as a result of its highly pathogenic variants, larg...
Genome sequencing has become a powerful tool for studying emerging infectious diseases; however, gen...
Objectives: Genome sequencing will be increasingly used in the clinical setting to tailor antimicrob...
Viruses are the main cause of respiratory tract infections. Metagenomic next-generation sequencing (...
Abstract Since the development of Sanger sequencing in 1977, sequencing technology has played a pivo...
Whole genome sequencing can be used to characterize and to trace viral outbreaks. Nanopore-based who...
The infrastructure challenges and costs of next-generation sequencing have been largely overcome, fo...
Metagenomic sequencing with the Oxford Nanopore MinION sequencer offers potential for point-of-care ...
Metagenomic sequencing with the Oxford Nanopore MinION sequencer offers potential for point-of-care ...
The use of the MinION sequencer (Oxford Nanopore) was tested on samples prepared to simulate infecti...
© 2015 Greninger et al.We report unbiased metagenomic detection of chikungunya virus (CHIKV), Ebola ...
As exemplified by the global response to the SARS-CoV-2 pandemic, whole-genome sequencing played an ...
Laboratories studying high-priority pathogens need comprehensive methods to confirm microbial specie...
Recently, protocols for amplicon based whole genome sequencing using Nanopore technology have been d...
Shotgun metagenomic sequencing (SMg) enables the simultaneous detection and characterization of viru...
Influenza is a major global public health threat as a result of its highly pathogenic variants, larg...
Genome sequencing has become a powerful tool for studying emerging infectious diseases; however, gen...
Objectives: Genome sequencing will be increasingly used in the clinical setting to tailor antimicrob...
Viruses are the main cause of respiratory tract infections. Metagenomic next-generation sequencing (...
Abstract Since the development of Sanger sequencing in 1977, sequencing technology has played a pivo...
Whole genome sequencing can be used to characterize and to trace viral outbreaks. Nanopore-based who...
The infrastructure challenges and costs of next-generation sequencing have been largely overcome, fo...